Showing results (111-120 of 123) with videos related to

Sort By:
Pageof 13
Journal of Medicinal Chemistry|June 27, 2009
Apogossypol derivatives as pan-active inhibitors of antiapoptotic B-cell lymphoma/leukemia-2 (Bcl-2) family proteinsJun Wei, Shinichi Kitada, Michele F Rega, et al.
CNS Neuroscience & Therapeutics|August 10, 2024
Hyperglycemia-induced Sirt3 downregulation increases microglial aerobic glycolysis and inflammation in diabetic neuropathic pain pathogenesisYongchang Li, Erliang Kong, Ruifeng Ding, et al.
Life Sciences|December 2, 2019
A bidirectional effect of Rac1 inhibition-Protects radiation-induced intestinal injury while inhibits tumorNi An, Tingting Liu, Baoliang Zhu, et al.
Bioorganic & Medicinal Chemistry Letters|November 18, 2008
Molecular modeling, synthesis, and activity studies of novel biaryl and fused-ring BACE1 inhibitorsSrinivas Reddy Chirapu, Boobalan Pachaiyappan, Hikmet F Nural, et al.
Molecular Cancer Therapeutics|November 7, 2013
Small-molecule IAP antagonists sensitize cancer cells to TRAIL-induced apoptosis: roles of XIAP and cIAPsDarren Finlay, Mitchell Vamos, Marcos González-López, et al.
Bioorganic & Medicinal Chemistry Letters|June 18, 2011
Design, synthesis and evaluation of monovalent Smac mimetics that bind to the BIR2 domain of the anti-apoptotic protein XIAPMarcos González-López, Kate Welsh, Darren Finlay, et al.
Nature Communications|February 20, 2021
E3 ligase Nedd4l promotes antiviral innate immunity by catalyzing K29-linked cysteine ubiquitination of TRAF3Peng Gao, Xianwei Ma, Ming Yuan, et al.
ACS Medicinal Chemistry Letters|October 18, 2011
Identification of Inhibitors of NOD1-Induced Nuclear Factor-κB ActivationPasha M Khan, Ricardo G Correa, Daniela B Divlianska, et al.
Molecular Cancer Therapeutics|April 18, 2009
Apogossypol derivatives as antagonists of antiapoptotic Bcl-2 family proteinsJun Wei, Shinichi Kitada, Michele F Rega, et al.
Bioorganic & Medicinal Chemistry Letters|July 2, 2015
Discovery of 2-arylamino-4-(1-methyl-3-isopropylsulfonyl-4-pyrazol-amino)pyrimidines as potent anaplastic lymphoma kinase (ALK) inhibitorsPeilong Zhang, Jiaqiang Dong, Boyu Zhong, et al.
Pageof 13